CBS 2019
CBSMD教育中心
中 文

肺动脉高压

Abstract

Recommended Article

Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Update on chronic thromboembolic pulmonary hypertension Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study Medical Therapy for CTEPH: Is There Still Space for More? Active and Passive Vaccination for Pulmonary Arterial Hypertension: A Novel Therapeutic Paradigm

Clinical TrialAvailable online 7 April 2021

JOURNAL:JACC: Heart Failure Article Link

Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial

D Burkhoff, BA Borlaug, SJ Shah et al. Keywords: PH-HFpEF; pulmonary capillary wedge pressure; 6MWD

Full Text PDF